Altamira Therapeutics (CYTO)
NASDAQ:CYTO
US Market
Holding CYTO?
Track your performance easily

Altamira Therapeutics (CYTO) Stock Forecast & Price Target

593 Followers
See the Price Targets and Ratings of:

CYTO Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Altamira
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CYTO Stock 12 Month Forecast

There Are No Analyst Ratings for CYTO In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CYTO Financial Forecast

CYTO Earnings Forecast

Next quarter’s earnings estimate for CYTO is -$0.60 with a range of -$0.60 to -$0.60. The previous quarter’s EPS was -$2.11. CYTO beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.54% of the time in the same period. In the last calendar year CYTO has Outperformed its overall industry.
Next quarter’s earnings estimate for CYTO is -$0.60 with a range of -$0.60 to -$0.60. The previous quarter’s EPS was -$2.11. CYTO beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.54% of the time in the same period. In the last calendar year CYTO has Outperformed its overall industry.

CYTO Sales Forecast

Next quarter’s sales forecast for CYTO is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CYTO beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.79% of the time in the same period. In the last calendar year CYTO has Underperformed its overall industry.
Next quarter’s sales forecast for CYTO is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CYTO beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.79% of the time in the same period. In the last calendar year CYTO has Underperformed its overall industry.

CYTO Analyst Recommendation Trends

Rating
Jul 16
Aug 16
Nov 16
Jun 17
Oct 18
Strong Buy
0
0
0
0
0
Buy
5
6
4
4
3
Hold
0
1
2
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
7
6
6
4
In the current month, CYTO has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CYTO average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

CYTO Stock Forecast FAQ

What is CYTO’s average 12-month price target, according to analysts?
Currently, no data Available
What is CYTO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CYTO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CYTO a Buy, Sell or Hold?
      Currently, no data Available
      What is Altamira Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Altamira Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CYTO?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis